Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-11

Clinical Trial Update: Early Bactericidal Activity of TBA-7371 in Pulmonary Tuberculosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing early bactericidal activity of TBA-7371 in pulmonary tuberculosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TBA-7371

Snippet

Sponsor: Gates Medical Research Institute | Conditions: Pulmonary Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2024-04-11